PepGen Ltd (NASDAQ: PEPG) — Healthcare · Share Price, Chart & Market Data
About: PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.54 (-3.14%)
PEPGPepGen Ltd
Loading watchlist status…
Trade PEPG now
PepGen Ltd share price
PEPG price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:55 am GMT+0
PEPG price performance
-10.983%
5D
-67.373%
1M
-78.522%
YTD
-8.333%
1Y
PEPG price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:55 am GMT+0
PEPG details
PEPG Market Signals